Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Sarcopenia and Diabetes Mellitus

Authors not listed

Dionyssiotis, Yannis, M.D. · 2018

Abstract

The association of diabetes mellitus type 2 (T2DM) with sarcopenia has not been adequately investigated. Sarcopenia is characterized by progressive and generalized loss of skeletal muscle mass which may affect performance.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-18 MST

Cite this

APA
Anonymous. (2018). Sarcopenia and Diabetes Mellitus. <em>Dionyssiotis, Yannis, M.D.</em>. https://clinicaltrials.gov/study/NCT04407819
Vancouver
Anonymous. Sarcopenia and Diabetes Mellitus. Dionyssiotis, Yannis, M.D.. 2018.
BibTeX
@misc{anon2018Sarcop, title = {Sarcopenia and Diabetes Mellitus}, author = {Anonymous}, journal = {Dionyssiotis, Yannis, M.D.}, year = {2018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

Wiener Medizinische Wochenschrift 2018
Citation only

Sarcopenia

▲ 102
Clinics in Geriatric Medicine 2010
Citation only

Sarcopenia

▲ 94
Clinics in Geriatric Medicine 2017
Citation only

Sarcopenia

▲ 125
Nature Reviews Disease Primers 2024
Citation only

Sarcopenia

▲ 381
The Lancet 2019
Citation only

Sarcopenia

▲ 3,875
Joint Bone Spine 2018
Open access · OA

Sarcopenia

▲ 370